187 related articles for article (PubMed ID: 12072880)
1. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.
Leung DY; Meissner HC; Shulman ST; Mason WH; Gerber MA; Glode MP; Myones BL; Wheeler JG; Ruthazer R; Schlievert PM
J Pediatr; 2002 Jun; 140(6):742-6. PubMed ID: 12072880
[TBL] [Abstract][Full Text] [Related]
2. [Kawasaki disease and infection].
Komatsu H; Fujisawa T
Nihon Rinsho; 2008 Feb; 66(2):278-82. PubMed ID: 18260325
[TBL] [Abstract][Full Text] [Related]
3. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Leung DY; Meissner HC; Fulton DR; Murray DL; Kotzin BL; Schlievert PM
Lancet; 1993 Dec; 342(8884):1385-8. PubMed ID: 7901681
[TBL] [Abstract][Full Text] [Related]
4. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
[TBL] [Abstract][Full Text] [Related]
5. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
Leung DY; Sullivan KE; Brown-Whitehorn TF; Fehringer AP; Allen S; Finkel TH; Washington RL; Makida R; Schlievert PM
Pediatr Res; 1997 Sep; 42(3):268-72. PubMed ID: 9284264
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease.
Gupta-Malhotra M; Viteri-Jackson A; Thomas W; Zabriskie JB
Exp Mol Pathol; 2004 Apr; 76(2):117-21. PubMed ID: 15010289
[TBL] [Abstract][Full Text] [Related]
7. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease.
Terai M; Miwa K; Williams T; Kabat W; Fukuyama M; Okajima Y; Igarashi H; Shulman ST
J Infect Dis; 1995 Aug; 172(2):558-61. PubMed ID: 7622905
[TBL] [Abstract][Full Text] [Related]
8. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease.
Matsubara K; Fukaya T
Curr Opin Infect Dis; 2007 Jun; 20(3):298-303. PubMed ID: 17471041
[TBL] [Abstract][Full Text] [Related]
9. Superantigen can reactivate bacterial cell wall-induced arthritis.
Schwab JH; Brown RR; Anderle SK; Schlievert PM
J Immunol; 1993 May; 150(9):4151-9. PubMed ID: 8473753
[TBL] [Abstract][Full Text] [Related]
10. Detection of multiple superantigen genes in stools of patients with Kawasaki disease.
Suenaga T; Suzuki H; Shibuta S; Takeuchi T; Yoshikawa N
J Pediatr; 2009 Aug; 155(2):266-70. PubMed ID: 19446844
[TBL] [Abstract][Full Text] [Related]
11. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS).
Harrison LM; Morris JA; Bishop LA; Lauder RM; Taylor CA; Telford DR
FEMS Immunol Med Microbiol; 2004 Sep; 42(1):94-104. PubMed ID: 15325402
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins).
Braun MA; Gerlach D; Hartwig UF; Ozegowski JH; Romagné F; Carrel S; Köhler W; Fleischer B
J Immunol; 1993 Mar; 150(6):2457-66. PubMed ID: 8450222
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
Fukushima H; Hirano T; Oka K
Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
[TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Nishiyori A; Sakaguchi M; Kato H; Igarashi H; Miwa K
Lancet; 1994 Jan; 343(8892):299-300. PubMed ID: 7905128
[No Abstract] [Full Text] [Related]
15. Superantigenic exotoxin production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children.
Todome Y; Ohkuni H; Mizuse M; Okibayashi F; Ohtani N; Suzuki H; Song C; Igarashi H; Harada K; Sakurai S
J Med Microbiol; 1995 Feb; 42(2):91-5. PubMed ID: 7869353
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of Kawasaki disease and superantigens.
Uchiyama T; Kato H
Jpn J Infect Dis; 1999 Aug; 52(4):141-5. PubMed ID: 10592892
[TBL] [Abstract][Full Text] [Related]
17. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome.
Nomura Y; Yoshinaga M; Masuda K; Takei S; Miyata K
J Infect Dis; 2002 Jun; 185(11):1677-80. PubMed ID: 12023778
[TBL] [Abstract][Full Text] [Related]
18. [A new exanthematous disease in newborn infants caused by exotoxins producing Staphylococcus aureus; exotoxins production of the isolates and serum levels of antitoxin antibody in the patients and umbilical cord blood].
Okada T; Furukawa S; Miwa K; Sakai R; Sugiyama J
Kansenshogaku Zasshi; 1999 Sep; 73(9):893-900. PubMed ID: 10535264
[TBL] [Abstract][Full Text] [Related]
19. Purpura fulminans due to Staphylococcus aureus.
Kravitz GR; Dries DJ; Peterson ML; Schlievert PM
Clin Infect Dis; 2005 Apr; 40(7):941-7. PubMed ID: 15824983
[TBL] [Abstract][Full Text] [Related]
20. Long-time persistence of superantigen-producing Staphylococcus aureus strains in the intestinal microflora of healthy infants.
Lindberg E; Nowrouzian F; Adlerberth I; Wold AE
Pediatr Res; 2000 Dec; 48(6):741-7. PubMed ID: 11102540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
